Measuring Disease Damage and Its Severity in Childhood‐Onset Systemic Lupus Erythematosus
- 26 October 2018
- journal article
- research article
- Published by Wiley in Arthritis Care & Research
- Vol. 70 (11) , 1621-1629
Abstract
Objective: To describe the frequency and types of disease damage occurring with childhood‐onset systemic lupus erythematosus (SLE) as measured by the 41‐item Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI), and to assess the SDI's ability to reflect damage severity.Methods: Information for the SDI was prospectively collected from 1,048 childhood‐onset SLE patients. For a subset of 559 patients, physician‐rated damage severity measured by visual analog scale (MD VAS damage) was also available. Frequency of SDI items and the association between SDI summary scores and MD VAS damage were estimated. Finally, an international consensus conference, using nominal group technique, considered the SDI's capture of childhood‐onset SLE–associated damage and its severity.Results: After a mean disease duration of 3.8 years, 44.2% of patients (463 of 1,048) already had an SDI summary score >0 (maximum 14). The most common SDI items scored were proteinuria, scarring alopecia, and cognitive impairment. Although there was a moderately strong association between SDI summary scores and MD VAS damage (Spearman's r = 0.49, P < 0.0001) in patients with damage (SDI summary score >0), mixed‐effects analysis showed that only 4 SDI items, each occurring in <2% of patients overall, were significantly associated with MD VAS damage. There was consensus among childhood‐onset SLE experts that the SDI in its current form is inadequate for estimating the severity of childhood‐onset SLE–associated damage.Conclusion: Disease damage as measured by the SDI is common in childhood‐onset SLE, even with relatively short disease durations. Given the shortcomings of the SDI, there is a need to develop new tools to estimate the impact of childhood‐onset SLE–associated damage.Keywords
Funding Information
- National Institutes of Health (5U01‐AR‐067166)
- Cincinnati Children’s Research Foundation
- University of Liverpool
- Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP 2015/03756‐4)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq 303422/2015‐7)
This publication has 14 references indexed in Scilit:
- Developing Core Outcome Measurement Sets for Clinical Trials: OMERACT Filter 2.0Journal of Clinical Epidemiology, 2014
- Cancer risk in childhood-onset systemic lupusArthritis Research & Therapy, 2013
- Differences in Autoantibody Profiles and Disease Activity and Damage Scores Between Childhood- and Adult-Onset Systemic Lupus Erythematosus: A Meta-AnalysisSeminars in Arthritis and Rheumatism, 2012
- Disease activity, severity, and damage in the UK juvenile‐onset systemic lupus erythematosus cohortArthritis & Rheumatism, 2012
- Interrater reliability and aspects of validity of the myositis damage indexAnnals of the Rheumatic Diseases, 2011
- Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment IndexAnnals of the Rheumatic Diseases, 2011
- A proposal for a pediatric version of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index based on the analysis of 1,015 patients with juvenile‐onset systemic lupus erythematosusArthritis & Rheumatism, 2006
- Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositisRheumatology, 2003
- An Experimental Test of a Theoretical Foundation for Rating-scale ValuationsMedical Decision Making, 1997
- The development and initial validation of the systemic lupus international collaborating clinics/American college of rheumatology damage index for systemic lupus erythematosusArthritis & Rheumatism, 1996